KALAKALA BIO, Inc.Aug 12, 2022Q2 2022
Read transcript →KALA BIO, Inc. (KALA) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$0.18
-5.91%
Mkt Cap $3.68M
KALAKALA BIO, Inc.Aug 12, 2022KALAKALA BIO, Inc.May 16, 2022Q1 2022
Read transcript →KALAKALA BIO, Inc.Mar 29, 2022Q4 2021
Read transcript →KALAKALA BIO, Inc.Nov 15, 2021Q3 2021
Read transcript →KALAKALA BIO, Inc.Aug 5, 2021Q2 2021
Read transcript →KALAKALA BIO, Inc.May 5, 2021Q1 2021
Read transcript →KALAKALA BIO, Inc.Feb 25, 2021Q4 2020
Read transcript →KALAKALA BIO, Inc.Nov 7, 2020Q3 2020
Read transcript →KALAKALA BIO, Inc.Aug 8, 2020Q2 2020
Read transcript →KALAKALA BIO, Inc.May 10, 2020Q1 2020
Read transcript →KALAKALA BIO, Inc.Feb 12, 2020Q4 2019
Read transcript →KALAKALA BIO, Inc.Nov 10, 2019Q3 2019
Read transcript →KALAKALA BIO, Inc.Aug 6, 2019Q2 2019
Read transcript →KALAKALA BIO, Inc.May 9, 2019Q1 2019
Read transcript →KALAKALA BIO, Inc.Mar 11, 2019Q4 2018
Read transcript →KALAKALA BIO, Inc.Mar 26, 2018Q4 2017
Read transcript →